Meridiem Capital Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
CIP
Meridiem Capital Partners's RGEN Position: Q3 2025 in Review
Meridiem Capital Partners sold out of Repligen (RGEN) in Q3 2025, closing a stake of 20,954 shares — an estimated $2.61M sold.
Meridiem Capital Partners first reported a position in RGEN in Q2 2025 and held it in 1 quarter. The position peaked at $2.61M in Q2 2025. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.
- Meridiem Capital Partners reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
- Meridiem Capital Partners sold 20,954 Repligen shares in Q3 2025, an estimated $2.61M.
- Meridiem Capital Partners first reported a position in Repligen in Q2 2025 and held it in 1 quarter.
- Meridiem Capital Partners's Repligen position peaked at $2.61M in Q2 2025.
- 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.
Based on Meridiem Capital Partners's 13F filing for Q3 2025, filed 13 Nov 2025.